MOB — Moberg Pharma AB (publ) Balance Sheet
0.000.00%
- SEK423.24m
- SEK190.00m
- SEK9.81m
- 43
- 21
- 43
- 23
Annual balance sheet for Moberg Pharma AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 19.3 | 103 | 126 | 60.6 | 293 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.16 | 1.14 | 1.44 | 0.786 | 0.804 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 167 | 105 | 128 | 69.5 | 300 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7.1 | 4.52 | 5.98 | 4.94 | 4.42 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 481 | 451 | 564 | 635 | 706 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 80.2 | 15.5 | 26.8 | 20.5 | 16.7 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 92.7 | 16.8 | 30.8 | 24 | 19.3 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 388 | 434 | 534 | 611 | 687 |
| Total Liabilities & Shareholders' Equity | 481 | 451 | 564 | 635 | 706 |
| Total Common Shares Outstanding |